Application 020334
- Type
- NDA
- Sponsor
- GD SEARLE LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FLAGYL | METRONIDAZOLE | CAPSULE;ORAL | 375MG | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0025-1942 | Flagyl | metronidazole | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0025-1942 | Flagyl | metronidazole | G.D. Searle LLC Division of Pfizer Inc | NDA | Current |
| 0025-1942 | Flagyl | metronidazole | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0025-1942 | Flagyl | metronidazole | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0025-1942 | Flagyl | metronidazole | Pfizer Laboratories Div Pfizer Inc | NDA | Current |
| 0025-1942 | Flagyl | metronidazole | G.D. Searle LLC Division of Pfizer Inc | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 79024 | SUPPL | 2024-07-09 |
| 79009 | SUPPL | 2024-07-09 |
| 75697 | SUPPL | 2023-10-10 |
| 75687 | SUPPL | 2023-10-10 |
| 69677 | SUPPL | 2021-12-20 |
| 69577 | SUPPL | 2021-12-16 |
| 66689 | SUPPL | 2021-03-09 |
| 66666 | SUPPL | 2021-03-09 |
| 53624 | SUPPL | 2018-04-05 |
| 53604 | SUPPL | 2018-04-04 |
| 34521 | SUPPL | 2015-07-16 |
| 2351 | SUPPL | 2015-07-14 |
| 34520 | SUPPL | 2013-08-21 |
| 2350 | SUPPL | 2013-08-20 |
| 24797 | SUPPL | 2010-08-24 |
| 34519 | SUPPL | 2010-08-20 |
| 12463 | SUPPL | 2004-04-05 |
| 24796 | SUPPL | 2004-03-24 |
| 2349 | SUPPL | 2003-05-29 |
| 34518 | SUPPL | 2003-04-28 |